{
    "2021-12-22": [
        [
            {
                "time": "",
                "original_text": "【权益变动】凯莱英(06821.HK)获FMR LLC增持1.76万股",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "FMR LLC",
                        "增持",
                        "1.76万股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CDMO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中信建投：持续看好创新药国际化及CDMO长期竞争力",
                "features": {
                    "keywords": [
                        "中信建投",
                        "创新药",
                        "国际化",
                        "CDMO",
                        "长期竞争力"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CDMO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}